Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

InspireMD (NSPR) Return on Equity (2016 - 2025)

Historic Return on Equity for InspireMD (NSPR) over the last 15 years, with Q3 2025 value amounting to 1.11%.

  • InspireMD's Return on Equity fell 4300.0% to 1.11% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.11%, marking a year-over-year decrease of 4300.0%. This contributed to the annual value of 0.85% for FY2024, which is 1500.0% down from last year.
  • According to the latest figures from Q3 2025, InspireMD's Return on Equity is 1.11%, which was down 4300.0% from 1.74% recorded in Q2 2025.
  • InspireMD's 5-year Return on Equity high stood at 0.3% for Q2 2021, and its period low was 1.74% during Q2 2025.
  • Its 5-year average for Return on Equity is 0.74%, with a median of 0.65% in 2024.
  • In the last 5 years, InspireMD's Return on Equity surged by 15800bps in 2021 and then crashed by -10800bps in 2025.
  • Quarter analysis of 5 years shows InspireMD's Return on Equity stood at 0.42% in 2021, then tumbled by -123bps to 0.94% in 2022, then surged by 46bps to 0.51% in 2023, then plummeted by -69bps to 0.87% in 2024, then fell by -28bps to 1.11% in 2025.
  • Its Return on Equity was 1.11% in Q3 2025, compared to 1.74% in Q2 2025 and 1.17% in Q1 2025.